Clinical trials in Halle (Saale) – page 2

Clinical research in Halle (Saale) is strongly focused on cancer and blood disorders, with studies exploring new treatment options for solid tumors and leukemia, lymphoma, and related conditions.

• Neoplasms and hematologic malignancies
• Acute myeloid leukemia, lymphoma, and multiple myeloma
• Testing newer combinations and more effective treatment strategies
• Evaluating outcomes in advanced, relapsed, or high-risk disease

Many studies in this area aim to improve survival, disease control, and treatment options for patients with limited standard choices.

Another major research area covers respiratory tract diseases, especially non-small cell lung cancer, small cell lung cancer, and chronic lung conditions such as COPD and pulmonary fibrosis.

• Non-small cell lung cancer and small cell lung cancer
• Chronic obstructive pulmonary disease, bronchiectasis, and idiopathic pulmonary fibrosis
• Assessing new therapies and maintenance approaches
• Improving symptom control and long-term respiratory outcomes

The studies often focus on better disease management for both advanced cancers and chronic inflammatory lung disease.

Trials in digestive system diseases and immune-related disorders include important work on Crohn’s disease, ulcerative colitis, and other inflammatory conditions of the gut.

• Crohn’s disease and ulcerative colitis
• Coeliac disease and gastrointestinal inflammation
• Studying new immune-targeted treatments
• Improving control of active disease and remission rates

These projects aim to reduce symptoms, support remission, and improve quality of life for people with chronic intestinal disease.

Cardiovascular diseases are represented by studies on heart failure, atrial fibrillation, stroke, and related complications after surgery or acute vascular events.

• Heart failure and atrial fibrillation
• Acute ischemic stroke and vascular occlusion
• Testing ways to prevent complications and improve recovery
• Evaluating safer and more effective cardiovascular care

Research in this field is aimed at lowering risk, improving emergency treatment, and supporting long-term heart and brain health.

Halle’s trial portfolio includes a broad set of studies on immune system diseases, including rheumatologic, skin-related, and other inflammatory conditions.

• Lupus erythematosus, hidradenitis suppurativa, and giant cell arteritis
• Atopic dermatitis and chronic spontaneous urticaria
• Exploring immune-modulating therapies
• Looking to reduce inflammation and improve daily functioning

These studies reflect a strong interest in better control of chronic immune-driven disease.

A significant share of research addresses myeloid disorders, myeloproliferative neoplasms, and complications linked to stem cell transplantation.

• Myelodysplastic syndromes, myelofibrosis, and essential thrombocythemia
• Graft-versus-host disease and transplant-related complications
• Evaluating better blood cancer and transplant treatments
• Improving safety and disease control in high-risk patients

Much of this work focuses on patients with difficult-to-treat disease and the need for more precise supportive care.

The city also supports research into children’s cancers and other rare pediatric conditions, including tumors of the brain, blood, and soft tissue.

• Medulloblastoma, neuroblastoma, and rhabdomyosarcoma
• Acute lymphoblastic leukemia in children and adolescents
• Testing more effective and less burdensome treatment approaches
• Seeking better survival and long-term outcomes for young patients

These trials often aim to refine treatment so that cure rates improve while limiting lasting harm.

Research also includes nervous system diseases such as stroke, multiple sclerosis, spinal cord injury, and certain rare neurological disorders.

• Secondary progressive multiple sclerosis
• Acute spinal cord injury and idiopathic sudden hearing loss
• Evaluating therapies that may improve recovery or slow progression
• Exploring care options for serious and uncommon neurological conditions

These studies are aimed at improving function, symptom relief, and neurological outcomes over time.

Trials in nutritional and metabolic diseases and kidney-related disorders focus on conditions that affect energy balance, organ function, and long-term health.

• Obesity, metabolic disease, and mitochondrial disease
• Chronic kidney disease and kidney-related complications
• Studying ways to slow disease progression
• Assessing treatments that may improve overall organ health

This area reflects interest in both common chronic illness and rarer inherited disorders.

Several studies address eye diseases, ear and nose conditions, and broader diagnostic techniques, showing a strong interest in improving how disease is detected and managed.

• Diabetic macular edema and other vision-threatening eye conditions
• Hearing loss and otologic disorders
• Improving diagnosis and monitoring
• Testing therapies that may preserve vision or sensory function

These projects highlight the role of better diagnostics alongside treatment development in everyday clinical care.

There is also work on bacterial infections, viral diseases, surgical complications, and public health questions, including prevention and perioperative care.

• Viral and bacterial infections
• Surgical bleeding, infection prevention, and post-operative complications
• Evaluating supportive treatments and preventive strategies
• Improving safety in hospital and surgical settings

These trials focus on practical clinical needs, from infection control to safer recovery after procedures.

Some research in Halle addresses mental disorders and behavioral disciplines, reflecting interest in both emotional health and broader patient well-being.

• Attention deficit hyperactivity disorder and borderline personality disorder
• Studying approaches that may improve symptoms and functioning
• Supporting better understanding of complex behavioral conditions
• Exploring patient-centered care in mental health

These studies contribute to broader clinical research beyond traditional somatic disease areas.

Trials also include female and male urogenital diseases, pregnancy-related issues, and fertility-related concerns, showing a balanced interest in reproductive health.

• Pregnancy complications and vaginal infections
• Infertility and urogenital disorders
• Testing therapies for symptom relief and prevention
• Improving health outcomes for women and men

These studies often aim to make everyday gynecologic and reproductive care more effective.